Congress Introduces SAFE Drugs Act of 2025, Expanding FDA Oversight of Compounded GLP-1 Drugs and Telehealth Providers - Dykema
The SAFE Drugs Act of 2025, if enacted, would expand FDA oversight of compounded GLP-1 drugs and telehealth providers, potentially imposing new compliance requirements on compounding pharmacies and telehealth practices.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Compounding pharmacies, telehealth providers, and independent pharmacies involved in compounding or prescribing GLP-1 drugs. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; bill is introduced, not yet law.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The bill proposes expanded FDA oversight of compounded GLP-1 drugs and telehealth providers, which may lead to new regulations, inspections, or reporting requirements.
Who it affects
Compounding pharmacies, telehealth providers, and independent pharmacies involved in compounding or prescribing GLP-1 drugs.
What you must do
Monitor legislative progress and assess current compounding and telehealth practices for potential compliance gaps.
Deadline
Not specified; bill is introduced, not yet law.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- PA HB 2731: An Act amending The Administrative Code of 1929, in powers and duties of the Department of Drug and Alcohol Programs
- FDA Announces Draft Guidance on Outsourcing Facility Sales - Quarles
- New Jersey Pharmacies Will Soon Be Able to Sell Birth Control Without a Prescription | Publications | Insights - Faegre Drinker
- Changes Coming For Prescribers To The Texas Prescription Drug Monitoring Program - JD Supra
- Illinois PBM Law to Limit Steering, Other Plan Design Features in 2026 - ogletree.com